Free Trial

Bicara Therapeutics (BCAX) Earnings Date, Estimates & Call Transcripts

Bicara Therapeutics logo
$18.22 -0.16 (-0.87%)
(As of 11:45 AM ET)

Bicara Therapeutics Latest Earnings Summary

Latest
Earnings Date
Nov. 12Estimated
Actual EPS
(Nov. 12)
-$1.60 Missed By -$1.14
Consensus EPS
(Nov. 12)
-$0.46

Bicara Therapeutics issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$1.60, which missed the consensus estimate of -$0.46 by $1.14. With a trailing EPS of $0.00, Bicara Therapeutics' earnings are expected to grow next year, from ($2.89) to ($1.65) per share.

Get Bicara Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bicara Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BCAX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BCAX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bicara Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($2.89) EPS
Next Year EPS Consensus Estimate: ($1.65) EPS

Bicara Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/12/2024--$0.46-$1.60 -$1.14-$1.60--

Bicara Therapeutics Earnings - Frequently Asked Questions

Bicara Therapeutics (NASDAQ:BCAX) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on BCAX's earnings history.

In the previous quarter, Bicara Therapeutics (NASDAQ:BCAX) missed the analysts' consensus estimate of ($0.46) by $1.14 with a reported earnings per share (EPS) of ($1.60). Learn more on analysts' earnings estimate vs. BCAX's actual earnings.

Bicara Therapeutics's earnings are expected to grow from ($2.89) per share to ($1.65) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:BCAX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners